Skip to main content

Exhibitor Seminar: Roche Diagnostics - HER2-low assessment: Challenges, Potential Solutions, and Clinical Impact

Date and Time: Tuesday, March 14, 2023, 5:30 PM - 7:00 PM CDT

Faculty: Paolo Tarantino, MD, Hannah Y. Wen, MD, PhD, and Sunil Shankar Badve, MD

Course Description
The goal of this symposium is to educate about the advances in metastatic breast cancer diagnosis and treatment implications. 

Learning Objectives

Learners will be able to:

  1. Understand the evolving classification of HER2 expression and testing in breast cancer
  2. Discuss challenges and potential solutions in HER2 IHC testing and interpretation
  3. Apply the knowledge gained to help improve pathologist communication to the oncologist for improved patient care. Listen to the dialogue between an oncologist and pathologists discuss their challenging cases.

Privacy Notice
The webinar is possible through Roche Diagnostics. This content is not available for continuing medical education. If you continue to register, you are acknowledging that your information will be shared with the company, including your name, degrees, institution, NPI number, mailing address, email address, and phone number. USCAP has no control over the use of this information.

The information presented represents the opinion of the presenters and is not necessarily the view of USCAP. USCAP does not endorse the products or services. The webinar is possible through Roche Diagnostics. This activity is not available for CME.